Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,191 | 225,801 | 298,720 | 318,103 | 523,668 |
| Marketable Securities | 664,301 | 580,445 | 522,028 | 468,976 | 448,895 |
| Receivables | 301,592 | 325,188 | 306,699 | 267,713 | 256,456 |
| Inventories | 215,524 | 216,833 | 210,439 | 182,446 | 182,928 |
| TOTAL | $1,356,608 | $1,348,267 | $1,337,886 | $1,237,238 | $1,411,947 |
| Non-Current Assets | |||||
| PPE Net | 191,489 | 194,805 | 199,692 | 193,995 | 196,632 |
| Investments And Advances | 357,586 | 374,968 | 435,189 | 536,348 | 552,939 |
| Intangibles | 12,718 | 12,718 | 11,820 | 0 | 0 |
| Other Non-Current Assets | 188,878 | 189,234 | 191,775 | 155,438 | 155,640 |
| TOTAL | $750,671 | $771,725 | $838,476 | $885,781 | $905,211 |
| Total Assets | $2,107,279 | $2,119,992 | $2,176,362 | $2,123,019 | $2,317,158 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 61,356 | 73,923 | 68,232 | 43,685 | 55,228 |
| Accrued Expenses | N/A | N/A | 68,739 | N/A | N/A |
| Other current liabilities | 313,495 | 300,529 | 295,147 | 351,108 | 558,730 |
| TOTAL | $374,851 | $374,452 | $432,118 | $394,793 | $613,958 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 32,799 | 0 | 0 |
| TOTAL | $26,148 | $31,826 | $32,799 | $31,672 | $30,092 |
| Total Liabilities | $400,999 | $406,278 | $464,917 | $426,465 | $644,050 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 679 | N/A | N/A |
| Retained earnings | N/A | N/A | 2,388,691 | N/A | N/A |
| Other shareholders' equity | 1,706,280 | 1,713,714 | -169,370 | 1,696,554 | 1,673,108 |
| TOTAL | $1,706,280 | $1,713,714 | $1,711,445 | $1,696,554 | $1,673,108 |
| Total Liabilities And Equity | $2,107,279 | $2,119,992 | $2,176,362 | $2,123,019 | $2,317,158 |